ArticleTherapeutic advances in musculoskeletal disease2026
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset.
Jiha Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.